Ishihara Sangyo Kaisha (4028) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
7 Aug, 2026Executive summary
FY2024 net sales increased by 4.9% year-over-year to ¥145.1B, but operating and ordinary profits declined due to weak titanium dioxide (TiO2) markets; net profit rose as prior-year impairment losses were absent.
FY2025 is forecasted for higher revenue and profit, with inorganic chemicals returning to profitability and organic chemicals maintaining growth.
Comprehensive income grew 6.9% year-over-year to ¥10,896 million.
Financial highlights
FY2024 revenue: ¥145.1B (up ¥6.7B YoY); operating profit: ¥10.4B (down ¥1B YoY); ordinary profit: ¥11.3B (down ¥3.4B YoY); net profit: ¥8.4B (up ¥0.4B YoY).
Dividend per share increased to ¥85 (up ¥15 YoY); FY2025 forecast: revenue ¥151B, operating profit ¥16.7B, net profit ¥10.3B.
Gross profit increased to ¥39,531 million from ¥37,101 million year-over-year.
Basic earnings per share rose to ¥219.98 from ¥209.27 year-over-year.
Cash and cash equivalents at period end rose to ¥24,948 million from ¥19,982 million.
Outlook and guidance
FY2025 expects increased sales in organic chemicals, especially herbicides in the Americas and insecticides in Asia.
Inorganic chemicals to see profit improvement as TiO2 inventory adjustments end and high-value products expand.
Dividend forecast raised to ¥100 per share (¥30 interim, ¥70 year-end).
Full-year profit per share forecasted at ¥240.46.
Latest events from Ishihara Sangyo Kaisha
- Net sales rose 10.4% but net income fell 80.6% due to forex losses and higher costs.4028
Q2 20257 Aug 2026 - Profits and forecasts surged on strong overseas sales, cost controls, and a favorable outlook.4028
Q2 20267 Aug 2026 - Q1 FY2027 saw steep profit declines and a major impairment loss in Inorganic Chemicals.4028
Q1 20277 Aug 2026 - Profits surged in FY2025, but FY2026/FY2027 is forecast to decline amid higher R&D and normalized demand.4028
Q4 20265 Jun 2026 - Strong profit growth and positive outlook, driven by Organic Chemicals segment.4028
Q3 202613 Feb 2026 - Q1 FY2025 profit dropped over 40% year-over-year despite stable sales; outlook revised down.4028
Q1 202520 Nov 2025 - Sales and operating income rose, but net income fell; dividend forecast increased.4028
Q3 202520 Nov 2025 - Operating profit surged 191% year-over-year, with strong sales and raised full-year guidance.4028
Q1 202620 Nov 2025